Source: PRFree

Press Release: Avaxia Biologics : Avaxia Biologics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Avaxia Biologics, Inc. (Avaxia) is a biotechnology company that provides solutions for gut-targeted antibody therapeutics. The company uses proprietary technology platform to develop recombinant, gut-targeted antibody therapeutics, called avaximabs.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Barbara S. Fox's photo - Founder & CEO of Avaxia Biologics

Founder & CEO

Barbara S. Fox

CEO Approval Rating

69/100

Read more